help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0482
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Sowers, M. R.
Right arrow Articles by Randolph, J. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sowers, M. R.
Right arrow Articles by Randolph, J. F., Jr.
Right arrowPubmed/NCBI databases
Hazardous Substances DB
*MENOTROPINS
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 10 3958-3964
Copyright © 2008 by The Endocrine Society

Follicle Stimulating Hormone and Its Rate of Change in Defining Menopause Transition Stages

MaryFran R. Sowers, Huiyong Zheng, Daniel McConnell, Bin Nan, Sioban Harlow and John F. Randolph, Jr.

Departments of Epidemiology (M.R.S., H.Z., D.M., S.H.) and Biostatistics (B.N.), School of Public Health, University of Michigan, and Department of Obstetrics and Gynecology (J.F.R.), University of Michigan Health Sciences System, Ann Arbor, Michigan 48109

Address all correspondence and requests for reprints to: MaryFran Sowers, Ph.D., Department of Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Room 1846, Ann Arbor, Michigan 48109. E-mail: mfsowers{at}umich.edu.

Context/Objective: The objective of the study was to identify menopause transition stages using acceleration or deceleration patterns of FSH rates of change from the late reproductive years to postmenopause.

Setting/Participants: Participants were the Michigan Bone Health and Metabolism Study cohort of 629 women, aged 24–44 yr (in 1992/3), with 5757 annual FSH data points over a 14-yr period.

Design/Main Outcome Measures: The study was designed to relate acceleration/deceleration patterns in FSH rate of change to time to final menstrual period (FMP) and chronological age using nonparametric and piecewise regression modeling.

Results: Four major FSH stages, based on rate of FSH change patterns, were identifiable in relation to the FMP. In FSH stage 1, the rate of FSH change increased modestly up to –7 yr prior to the FMP; in FSH stage 2 (–7 to –2 yr prior to FMP), there was a major acceleration in FSH rate of change. FSH stage 3 had an acute increase in FSH rate of change (–2 to +1 yr around the FMP), with average FSH level of 34 mIU/ml. The fourth, or plateau, FSH stage began at 1 yr after FMP when the average FSH level was 54 mIU/ml. During the yr 28–60, there were eight age-specific epochs defined by significant changes of FSH trajectory accelerations or decelerations and rate of change.

Conclusions: Four menopause transition stages bounding the FMP and eight epochs in chronological aging from age 28 to 60 yr were defined by changes of FSH trajectory accelerations/decelerations and rates of change. This timing information, combined with knowledge of FSH levels and menstrual cycle characteristics, can help discern the likely status of women with respect to their reproductive viability and menopause transition stage.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society